PharmaShots | Incisive News in 3 Shots

Subscribe Now

alderma

Galderma Reports Results from the P-III (READY-3) Study of RelabotulinumtoxinA for Treating Frown Lines and Crow’s Feet

Galderma Reports Results from the P-III (READY-3) Study of RelabotulinumtoxinA for Treating Frown Lines and Crow’s Feet

January 17, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us